News
SCNX
0.3228
-1.19%
-0.0039
SCIENTURE PROVIDES ANNUAL SHAREHOLDER UPDATE, OUTLINING SIGNIFICANT PROGRESS AND STRATEGIC PRIORITIES FOR THE YEAR AHEAD
Reuters · 1d ago
Weekly Report: what happened at SCNX last week (0330-0403)?
Weekly Report · 1d ago
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 03/30 17:05
BUZZ-U.S. STOCKS ON THE MOVE-Agnico Eagle Mines, ProPetro, Kezar
Reuters · 03/30 15:53
Scienture Holdings Posts Strong Revenue Growth For 2025; Stock Down
NASDAQ · 03/30 15:50
Scienture Holdings, Inc. GAAP EPS of -$2.70, revenue of $0.43M
Seeking Alpha · 03/30 13:23
Scienture FY25 operating loss widens to $42.6 million; gross margin climbs 7,240 bps to 76.8%
Reuters · 03/30 12:10
*Scienture Holdings 2025 Loss/Shr $2.70 >SCNX
Dow Jones · 03/30 12:09
*Scienture Holdings 2025 Rev $431,609 >SCNX
Dow Jones · 03/30 12:08
SCIENTURE REPORTS YEAR END 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
Reuters · 03/30 12:07
EXCLUSIVE: Penny Stock Scienture Reports Revenue Surge, Expanding Market Access In 2025
Benzinga · 03/30 11:46
Weekly Report: what happened at SCNX last week (0323-0327)?
Weekly Report · 03/30 09:37
Scienture Holdings: Q4 Earnings Snapshot
Barchart · 03/30 07:32
Weekly Report: what happened at SCNX last week (0316-0320)?
Weekly Report · 03/23 09:35
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 03/17 21:12
Weekly Report: what happened at SCNX last week (0309-0313)?
Weekly Report · 03/16 09:35
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 03/12 17:05
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 03/11 21:06
BUZZ-U.S. STOCKS ON THE MOVE-Agricultural stocks, Papa John's, Oil companies
Reuters · 03/11 18:02
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 03/11 17:06
More
Webull provides a variety of real-time SCNX stock news. You can receive the latest news about Scienture Holdings, Inc through multiple platforms. This information may help you make smarter investment decisions.
About SCNX
Scienture Holdings, Inc., through its wholly owned subsidiary, Scienture, LLC, is a specialty pharmaceutical company focused on providing enhanced value to patients, physicians and caregivers by offering specialty products to satisfy unmet market needs. Scienture, LLC is focused on developing and commercializing products for the treatment of central nervous system and cardiovascular diseases. Scienture LLC is developing a range of product candidates, including new potential treatments for hypertension, migraine, pain and thrombosis and other related disorders. The Company's product candidates include SCN- 102 (hypertension), SCN- 104 (CNS-Pain), SCN- 106 (Cardiovascular) and SCN- 107 (Pain). SCN-102 is an oral liquid formulation of losartan potassium in development for the treatment of hypertension. SCN-104 is a multi-dose pen-based delivery system for self-injection and increased patient convenience, which is in development for the acute treatment of migraine headaches.